Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
PURPOSE To provide precise age-specific risk estimates of cancers other than female breast and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for effective cancer risk management. METHODS We used data from 3,184 BRCA1 and 2,157 BRCA2 families in the Consortium of Invest...
Saved in:
Similar Items
-
Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
by: Kang, P., et al.
Published: (2010) -
Predicting the likelihood of carrying a BRCA1 or BRCA2 Mutation in Asian patients with breast cancer
by: Ang, Boon Hong, et al.
Published: (2022) -
BRCA1, BRCA2 mutations and the association with the clinicopathological characteristics of women with early-onset breast cancer
by: Ghazali, Mohamad Bazli
Published: (2014) -
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
by: Lakeman, Inge M. M., et al.
Published: (2021) -
Evaluation of Cancer-Based Criteria for Use in MainstreamBRCA1andBRCA2Genetic Testing in Patients With Breast Cancer
by: Kemp, Zoe, et al.
Published: (2019)